Formulation Development of Aceclofenac Nanosuspension as an Alternative Approach for Improving Drug Delivery of Poorly Soluble Drugs

DOI:

https://doi.org/10.37285/ijpsn.2013.6.3.6

Authors

  • S. Lakshmana prabu
  • S P Sharavanan
  • S Govindaraju
  • T N K Suriyaprakash

Abstract

Poor water solubility of active pharmaceutical ingredients is a major problem in drug discovery and formulation development. Nanoparticle engineering process has been seen as a promising approach for the enhancement of drug solubility. In this study, we present an approach of nanosizing a drug/polymeric complex to increase both solubility and dissolution rate of poorly-water soluble drug aceclofenac, which is widely used as anti-inflammatory drug. Polymeric nanosuspensions were prepared by nanoprecipitation method by using biodegradable polymer loaded with aceclofenac, with the aim to improve anti-inflammatory therapy. The prepared formulation was evaluated for drug excipients compatibility study, polydispersity index, particle size analysis, surface morphology, zeta potential, drug release features and stability. These study results indicate the suitability of formulation procedure for preparation of nanosized poorly-water soluble drug formulation with significantly improved in vitro dissolution rate and fast onset of therapeutic drug effect.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Aceclofenac, Nanosuspension, Tween 80, Dissolution, Anti-inflammatory drug.

Downloads

Published

2013-11-30

How to Cite

1.
prabu SL, Sharavanan SP, Govindaraju S, Suriyaprakash TNK. Formulation Development of Aceclofenac Nanosuspension as an Alternative Approach for Improving Drug Delivery of Poorly Soluble Drugs. Scopus Indexed [Internet]. 2013 Nov. 30 [cited 2024 Jul. 27];6(3):2145-53. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/634

Issue

Vol. 6 No. 3 (2013): October-December 2013

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Robert Langer R and Farokhzad OC (2008). New frontiers in nanotechnology for cancer treatment. Urol Oncol 26: 74-85.

Bakan J, Powell T and Szotak P (1991). Recent advances in microencapsulation of drugs to obtain reduced gastric irritation. In Nanoparticles in medicine pharmacy. (Donbrow M eds), Boca Raton (Fla): CRC Press; pp. 183-192.

Caruso F (2003). Hollow inorganic capsules via colloid-templated layer-by-layer electrostatic assembly. Top Curr Chem 226 & 227: 145-168.

Dolenc A, Kristl J, Baumgartner S and Planinsek O (2009). Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 376: 204–212.

Fichera M, Keck C and Muller RH (2004). Nanopure® Technology – Drug Nanocrystals for the Delivery of Poorly Soluble Drugs, Particles 2004 –Particle Synthesis, Characterization and Particle-Based Advanced Materials. Orlando, FL.

Hao E, Schatz GC and Hupp JT (2004). Synthesis and optical properties of anisotropic metal nanoparticles. J Fluorescence 14: 331-340.

Loganathan V, Senthil Kumar K, Siva Prasada Reddy MV, Sreekanth N and Senthil Kumar B (2003). Studies on preformulation compatibility between lomefloxacin and tablet excipients through DSC and X-ray diffraction analysis. Int J Pharmaceutical Excipients April-June: 38-49.

Patravale VB, Date AA and Kulkarni RM (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56: 827–840.

Pignatello R, Bucolo C, Ferrar P, Maltese A, Puleo A and Puglisi G (2002). Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 16: 53-61.

Rabinow BE (2004). Nanosuspensions in drug delivery. Nat Rev Drug Disco 3: 785–796.